Scott Berger
Houston, TXNPI 1093343246
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.8% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,924, 9.0 times the $215 reported in 2022.
Across 90 payments — averaging $45.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$711
- Sanofi$710
- Johnson & Johnson$552
- Phathom Pharmaceuticals, Inc.$297
- Regeneron Healthcare Solutions, Inc.$281
- Janssen Scientific Affairs, LLC$241
- plus $1K from 13 others
What the payments were for
- Food & beverage$4,00597%
- Education$1323%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 19 | $711 |
| Sanofi | 14 | $710 |
| Johnson & Johnson | 7 | $552 |
| Phathom Pharmaceuticals, Inc. | 5 | $297 |
| Regeneron Healthcare Solutions, Inc. | 6 | $281 |
| Janssen Scientific Affairs, LLC | 2 | $241 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $215 |
| Intercept Pharmaceuticals, Inc. | 2 | $211 |
| Ardelyx, Inc. | 4 | $194 |
| Madrigal Pharmaceuticals | 3 | $157 |
| Gilead | 1 | $124 |
| Boston Scientific | 2 | $116 |
| Celltrion USA Inc. | 5 | $90 |
| Aimmune Therapeutics, Inc. | 3 | $90 |
| Pfizer | 2 | $39 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $36 |
| Lilly USA, LLC | 1 | $30 |
| Dynavax Technologies Corporation | 1 | $26 |
| Braintree Laboratories, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 19 | $741 |
| Pantoprazole Sodium | 28 | $402 |
| Famotidine | 15 | $202 |
| Omeprazole | 12 | $196 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.